tirzepatide and seizures GLP-1 receptor agonists in people with epilepsy: A scoping review of clinical data, safety, therapeutic implications Could GLP-1 Drugs Lower Epilepsy

The law recognizes that when a drug manufacturer knowingly withholds critical safety information or downplays emerging evidence of harm, injured patients deserve justice

A peer-reviewed study published earlier this year indicates that only 40% of obese patients taking semaglutide-based GLP-1 products were persistent at one year

Keep reading to see how every stage in the dosing schedule adds to greater weight loss in the end

If each new vial from a different batch performs differently, storage during shipping could be the issue

Neither of these drugs is a "magic wand." Clinical trials show that these medications work best when combined with: 1